Herman, Herman & Katz Llc

Drugmaker Auxilium wins at jury in its first bellwether trial over testosterone therapy drug Testim

By Jonathan Bilyk | Thursday, Nov 16, 2017 @ 4:16pm

While their competitor AbbVie seeks to undo jury verdicts worth nearly $290 million over testosterone replacement therapy drugs, drugmaker Auxilium has received a clean bill from a jury in its first court test over claims it and other similar drugmakers should be made to pay for alleged misleading marketing that led men to take the drugs, and suffered heart attacks as a result.
Judge: Testosterone replacement drug bellwether OK to proceed vs Testim maker Auxilium

By Jonathan Bilyk | Tuesday, Oct 24, 2017 @ 4:44pm

After two federal juries delivered $140 million verdicts against AbbVie, competing drugmaker Auxilium will be headed to trial over claims its testosterone replacement therapy drug Testim caused heart attacks in men who took the drug to treat “off-label” conditions, spurred by what plaintiffs alleged was misleading marketing from drugmakers.